A Comparison of Methods for Thorough QT Analysis for the Assessment of Cardiac Safety.
- Published in:
- Pharmaceutical Medicine, 2016, v. 30, n. 1, p. 15, doi. 10.1007/s40290-015-0123-5
- By:
- Publication type:
- Article
Works matching IS 11782595 AND DT 2016 AND VI 30 AND IP 1
Results: 7
1
2
The Saudi Arabia Food and Drug Authority: An Evaluation of the Registration Process and Good Review Practices in Saudi Arabia in Comparison with Australia, Canada and Singapore.
- Published in:
- Pharmaceutical Medicine, 2016, v. 30, n. 1, p. 37, doi. 10.1007/s40290-015-0124-4
- By:
- Publication type:
- Article
3
Clinical Trial Regulations in India: Progress and Challenges Arising from Recent Amendments to Schedule Y of the Drugs and Cosmetics (D&C) Act 1940 (D&C Rules 1945).
- Published in:
- Pharmaceutical Medicine, 2016, v. 30, n. 1, p. 1, doi. 10.1007/s40290-015-0127-1
- By:
- Publication type:
- Article
4
Accreditation Standards for Medical Science Liaison (MSL) Certification Programmes in Japan: A Viewpoint from the Japanese Association of Pharmaceutical Medicine (JAPhMED).
- Published in:
- Pharmaceutical Medicine, 2016, v. 30, n. 1, p. 23, doi. 10.1007/s40290-015-0129-z
- By:
- Publication type:
- Article
5
Major Pharmaceutical Conferences and Courses.
- Published in:
- Pharmaceutical Medicine, 2016, v. 30, n. 1, p. 67, doi. 10.1007/s40290-015-0130-6
- Publication type:
- Article
6
Forum.
- Published in:
- Pharmaceutical Medicine, 2016, v. 30, n. 1, p. 57, doi. 10.1007/s40290-015-0131-5
- Publication type:
- Article
7
Early Trial Discontinuation in Toxicity-Driven, Dose-Escalating, Phase I Cancer Trials: Occurrence, Outcomes and Predictive Factors.
- Published in:
- Pharmaceutical Medicine, 2016, v. 30, n. 1, p. 49, doi. 10.1007/s40290-015-0120-8
- By:
- Publication type:
- Article